Position in ERAS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,838,132
+$3,542,435 QoQ
Shares Held
864,527
+13.8% QoQ
Ownership
0.247%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 257 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. ERAS ranks #45 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in ERAS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,838,132 | 864,527 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $12,295,697 | 759,932 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,226,836 | 329,795 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $614,812 | 282,025 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $218,725 | 172,226 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $155,607 | 113,583 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $122,162 | 48,671 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $102,047 | 37,381 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $77,433 | 32,811 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $60,262 | 29,254 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $67,728 | 31,798 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $47,053 | 23,885 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $60,473 | 21,911 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $68,831 | 22,868 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $97,637 | 22,654 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $177,691 | 22,781 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $127,991 | 22,979 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $142,380 | 16,556 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $167,437 | 10,747 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||